Artemis Company Profile

05:25 EDT 20th September 2017 | BioPortfolio



2064 Antioch Court, Suite B
United States of America


Phone: 510-339-4191
Fax: 510-339-4195

News Articles [11 Associated News Articles listed on BioPortfolio]

Artemis Health Secures $16 Million Series B Round to Equip Employers with Actionable Employment ...

SALT LAKE CITY, UT--(Marketwired - August 16, 2017) -Artemis Health, a company that offers a benefit optimization data platform for employers, received Read more...

Artemis Investment Management LLP Purchases New Holdings in Mylan N.V.

Artemis Investment Management LLP purchased a new stake in Mylan N.V. in the 2nd quarter, according to its most recent filing with the SEC. The institutional investor purchased 60,000 shares of the co...

Artemis Health Raises $8.3 Million Series A Round to Expand Benefits Optimization Platform

SALT LAKE CITY, UT--(Marketwired - May 09, 2017) - Artemis Health, a health data analytics company, raised $8.3 million in Series A funding to empower employers with needed transparency and insights i...

Central pathology review with two-stage quality assurance for pathological response after neoadjuvant chemotherapy in the ARTemis Trial

Artemis Health Secures $16 Million Series B Round to Equip Employers with Actionable Employment Benefits Data

SALT LAKE CITY, UT--(Marketwired - August 16, 2017) - Artemis Health, a company that offers a benefit optimization data platform for employers, received $16 million in Series B funding. The investment...

Aimmune Enrolls First Patient In ARTEMIS (ARC010) European Phase III Clinical Trial Of AR101 For The Treatment Of Peanut Allergy

  Life Sciences Jobs   ...

Artemis Real Estate Partners, Ackerman & Co. and MLL Capital Acquire 423,411-Square-Foot CHRISTUS San Antonio Medical Portfolio

ATLANTA, Aug. 7, 2017 /PRNewswire/ -- A partnership between Artemis Real Estate Partners, Ackerman & Co. and MLL Capital has purchased a four-building medical office portfolio totaling 423,41...

Aimmune Therapeutics Enrolls First Patient in ARTEMIS (ARC010) European Phase 3 Clinical Trial ...

— Trial Will Augment Ongoing Phase 3 PALISADE Trial and Explore Endpoint of Tolerating at Least 1000-mg Dose of Peanut Protein to Support AR101 Regulatory Filings in Europe — Re...

PubMed Articles [6 Associated PubMed Articles listed on BioPortfolio]

Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negative early breast cancer: ARTemis Trial.

The ARTemis trial previously reported that addition of neoadjuvant bevacizumab (Bev) to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide (D-FEC) in HER2 negative breast cancer impro...

Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial.

Unconditioned unrelated donor bone marrow transplantation for IL7Rα- and Artemis-deficient SCID.

Recent advances in the study of immunodeficiency and DNA damage response.

DNA breaks can be induced by exogenous stimuli or by endogenous stress, but are also generated during recombination of V, D, and J genes (V(D)J recombination), immunoglobulin class switch recombinatio...

Euro 6 unregulated pollutant characterization and statistical analysis of aftertreatment device and driving condition impact on recent passenger car emissions.

This study aims to measure and analyze unregulated compound emissions for two Euro 6 diesel and gasoline vehicles. The vehicles were tested on a chassis dynamometer under various driving cycles: Artem...

Clinical Trials [8 Associated Clinical Trials listed on BioPortfolio]

Measurements of Myocardial Relaxation Time by MRI During Respiration

Measurement of T2 transversal relaxation time by magnetic resonance has a major interest in cardiac imagery. It has been initially used for quantitative evaluation of heart viability and m...

(ARTEMIS-IPF)Randomized, Placebo-Controlled Study to Evaluate Safety and Effectiveness of Ambrisentan in IPF

The ARTEMIS-IPF study is for people who have been diagnosed with IPF and are between 40-80 years of age. People who have been diagnosed early in the disease may be more responsive to treat...

MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy

The primary objective of this study is to determine the performance characteristics (sensitivity and specificity) of the Artemis Health Test to detect fetal Trisomy 21 (T21) compared to ka...

ARTEMIS DIANE T790M Mutation at Hospital Laboratories in Comparison With Central Laboratory

The study primary objective is to assess the concordance of T790M resistance mutation testing from hospital-based laboratories with T790M resistance mutation testing from a central laborat...

ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis

This Phase 3, randomized, double-blind, placebo-controlled, multicenter study will compare the efficacy and safety of ambrisentan to placebo in subjects with pulmonary hypertension associa...

Companies [9 Associated Companies listed on BioPortfolio]

Artemis Health Group

Artemis is the nation’s leading provider of specialty-specific electronic medical record (EMR), workflow and mobile patient engagement solutions to help bridge the gap betwee...

Artemis International, Inc.

ARTEMISPharmaceuticals GmbH

ARTEMIS has developed the ArteMice™ platform, a combination of rapid and sophisticated gene vector design, efficient and expert ES cell transfection techniques, novel blastocyst injection techniques...

ARTEMIS Pharmaceuticals

ARTEMIS Pharmaceuticals, based in Cologne Germany was founded in 1998 and has made significant advances to provide rapid, efficient and sophisticated techniques for the analysis of gene function in ve...

Artemis Search

We have been recruiting in the biotechnology arena since 1987. We offer COntract recruitment, executive search and research services exclusiviely to the biotech industry.

More Information about "Artemis" on BioPortfolio

We have published hundreds of Artemis news stories on BioPortfolio along with dozens of Artemis Clinical Trials and PubMed Articles about Artemis for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Artemis Companies in our database. You can also find out about relevant Artemis Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record